Correlation of blood biomarkers with microstructural brain injury in survivors of out-of-hospital cardiac arrest

Clicks: 2
ID: 331839
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #158 of 162 articles by views in Brain communications

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 162 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract In-hospital mortality among resuscitated out-of-hospital cardiac arrest (OHCA) patients remains high. Identifying patients who will benefit from intensive care while avoiding prolonged, potentially unnecessary treatments is essential. Blood-based biomarkers provide a novel method for evaluating brain injury. The ability of glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), neuron-specific enolase (NSE) and total-tau (t-tau) to measure white and grey matter injury is unestablished in comatose OHCA survivors treated with targeted temperature management (TTM) or xenon combined with TTM. We examined correlations between the biomarkers and white and grey matter injury assessed with diffusion tensor imaging (DTI). This was a randomised, single-blind, phase 2 clinical drug trial involving two multi-purpose intensive care units in Finland. It was conducted between August 2009 and March 2015. One hundred and ten comatose OHCA patients aged 24 to 76 years were randomly assigned to either inhaled xenon treatment combined with 24-hour TTM (33°C) (n=55, xenon group) or TTM alone (n=55, control group). MRI data were available from 96 patients, with a median imaging time of 53 hours (interquartile range, 47-64 hours) after OHCA. Biomarker data were obtained from 105 patients. In the control group of 48 patients, after adjusting for age, sex and site, a disruption of white matter microintegrity as measured by decreased fractional anisotropy FA of DTI, the primary endpoint of the trial, showed a significant negative correlation with NfL at 24 h, 48 h and 72 h (ρ -0.28 – -0.37; p<0.05), NSE at 48 h and 72 h (ρ -0.30 – -0.35; p <0.05) and t-tau only at 72 h (ρ -0.30; p <0.05). In the xenon group (n = 48), these correlations were absent at all timepoints. The NfL–FA partial correlations showed progressive divergence between the xenon and control groups, with a statistically significant between-group difference observed at 72 h (ρ = −0.37 vs. ρ = 0.14; p = 0.016). Cortical or basal ganglia grey matter mean diffusivity did not have consistent correlation with biomarker levels at different time points. No statistically significant differences were found between the xenon and control groups in the adjusted geometric mean levels of GFAP, NfL, NSE, or t-tau at various time points following OHCA. In conclusion, NfL correlated with fractional anisotropy in controls but not in the xenon group. This between-group difference reached significance at 72 h, suggesting that xenon may modify the relationship between axonal injury and white matter microstructure after OHCA. Trial registration - clinicaltrials.gov identifier: NCT00879892
Reference Key
openalex_W7221017553 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mikael V Laaksonen, Jussi P. Posti, Carita C. Hollmén, Kaj Blennow, Henrik Zetterberg, Jaakko K. Rinne, Sami M. M. Virtanen, Jani P. Saunavaara, Riitta Parkkola, Ruut M. Laitio, Olli Arola, Marja S. Hynninen, Emmi K. Ylikoski, Juha Martola, Marjaana S Tiainen, Risto O. Roine, Harry Scheinin, Mervyn Maze, Timo Roine, Tero J. Vahlberg, Timo T. Laitio, Xe-HYPOTHECA Working Group, Juhani Airaksinen, Juha Grönlund, Veli‐Pekka Harjola, Outi Inkinen, Kirsi Korpi, Jussi Niiranen, Eija Nukarinen, Klaus Tapio Olkkola, Mikko Pietilä, Antti Saraste, Päivi Silvasti, Marjut Varpula, Johanna E. Wennervirta
Journal Brain communications
Year 2026
DOI
10.1093/braincomms/fcag378
URL
https://doi.org/10.1093/braincomms/fcag378
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.